Orchestra BioMed Holdings, Inc. Lease, Cost
Orchestra BioMed Holdings, Inc. (OBIO) reported Lease, Cost of $240.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. lease, cost for the quarter ending 2026-06-30 was $240.00K, a 34.43% decline year-over-year.
- Orchestra BioMed Holdings, Inc. lease, cost for the quarter ending 2026-03-31 was $308.00K, a 11.75% decline year-over-year.
- Orchestra BioMed Holdings, Inc. lease, cost for the quarter ending 2025-06-30 was $366.00K.
- Orchestra BioMed Holdings, Inc. lease, cost for the quarter ending 2025-03-31 was $349.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month |
|---|---|---|
| 2026-06-30 | $240.00K 10-Q · filed 2026-08-10 | $548.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $308.00K 10-Q · filed 2026-05-12 | |
| 2025-06-30 | $366.00K 10-Q · filed 2026-08-10 | $715.00K 10-Q · filed 2026-08-10 |
| 2025-03-31 | $349.00K 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |